MedTrace Logo

The Effect of Mandala Art Therapy on Comfort Level in Patients Receiving HD Treatment

NCT06727045 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 98

Last updated 2025-03-12

No results posted yet for this study

Summary

This study was conducted to evaluate the effect of mandala painting on the comfort level of patients receiving HD treatment.

Conditions

  • Art Therapy
  • Mandala Painting
  • Hemodialysis Patients

Interventions

OTHER

Mandala Coloring

A literature review was conducted to determine the frequency and number of mandalas to be applied to the patients in the intervention group, and the average of the number of mandala sessions applied to different patient groups was obtained, and mandala application was performed during a total of eight hemodialysis sessions, every other day. Mandala painting was performed approximately 30 minutes after the start of HD treatment, considering the art therapist's recommendation and the symptoms that may develop during HD. Each mandala painting was performed with a structured and different mandala pattern. Since it was stated that the use of round patterns instead of square patterns was effective in increasing the comfort level, the booklet called "Mandala Booklet", consisting of 8 structured mandala patterns with round shapes and containing general information about mandala, was used in the study. The group was informed about the content of the booklet face to face. Dry pencils were prefer

Sponsors & Collaborators

  • Sanko University

    lead OTHER

Principal Investigators

  • Nimet Ovayolu, Prof. Dr. · Sanko University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-29
Primary Completion
2024-03-18
Completion
2024-04-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06727045 on ClinicalTrials.gov